H. Parker

Ms. H.
S.
Parker is an Independent Director at Codexis, Inc., a Chairman at Sangamo Therapeutics, Inc. and a Principal at Parker Bioconsulting.
She is on the Board of Directors at Codexis, Inc. and Global Partnerships.
Ms. Parker was previously employed as an Independent Director by Armata Pharmaceuticals, Inc., an Independent Director by Impel Pharmaceuticals, Inc., a Chief Executive Officer & Director by Infectious Disease Research Institute, an Independent Director by OncoGenex Pharmaceuticals, Inc., an Independent Director by Achieve Life Sciences, Inc., a Chief Executive Officer & Director by Targeted Genetics Corp., a President & Director by Receptech Corp., a President, Chief Executive Officer & Director by Immunex Corp., and a Chairman by C3 Jian LLC.
She also served on the board at Inventprise, Inc., StrideBio, Inc., Nexgenia, Inc., Neose Technologies, Inc., Biotechnology Innovation Organization, OncoGenex Technologies, Inc. and Regence BlueShield.
She received her undergraduate degree from the University of Washington and an MBA from the University of Washington.